Table 2.
Comparison of Outcomes by Group
| Early (n = 33) | Delayed (n = 73) | ORa (95% CI)a | |
|---|---|---|---|
| Transitional failure | 2 (6) | 7 (10) | 0.61 (0.06–3.47) |
| Resume ICII | 2 (6) | 6 (8) | 0.72 (0.07–4.3) |
| DKA recurrence | 0 (0) | 1 (1) | — |
| Rebound hyperglycemiab | 26 (81) | 59 (88) | 0.59 (0.16–2.29) |
| All hypoglycemia | 11 (33) | 40 (55) | 0.41 (0.16–1.05) |
| Hypoglycemia on ICII | 6 (18) | 23 (32) | 0.48 (0.14–1.43) |
| ICII held for hypoglycemia | 2 (6) | 17 (23) | 0.21 (0.02–1.003) |
| P Valuec | |||
|---|---|---|---|
| Time to anion gap closure, h | 7.8 (4.8–12.5) | 9.1 (5.7–10.8) | 0.73 |
| Time on ICII, h | 13.8 (9.5–16.9) | 17.1 (12.4–21.2) | 0.04 |
| FSBG in first 24 h, n | 18 (15.5–20) | 20 (17.5–22) | 0.06 |
| Length of stay | |||
| ICU, h | 34.0 (20.4–48.9) | 33.3 (22.7–42.8) | 0.83 |
| Hospital, d | 2 (2–3) | 2 (2–3) | 0.90 |
Data are reported as n (%) or median (interquartile range).
a
Calculated using Fisher exact test.
b
Total evaluable patients: 32 in the early group, 67 in the delayed group.
c
P values were calculated using a Mann-Whitney U test.